Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Iodine (131I) anti-tenascin monoclonal antibody 81C6

EU orphan designation number: EU/3/06/418   
Active ingredient: Iodine (131I) anti-tenascin monoclonal antibody 81C6
Indication: Treatment of glioma
Sponsor: Biological Consulting Europe Ltd
Wallace Building, Roslin BioCentre, Roslin, Midlothian, EH25 9PP, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/11/2006 Centralised Orphan - Designation EMEA/OD/050/06 (2006)5337 of 30/10/2006
29/06/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/050/06/T/01 (2007)3207 of 27/06/2007
11/12/2007 Centralised Orphan - Change of address
01/04/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/050/06/T/02 (2009)2491 of 27/03/2009
09/11/2010 Centralised Orphan - Change of address EMA/581017/2010
30/12/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/050/06/T/03 (2010)9546 of 17/12/2010
29/08/2014 Centralised Orphan - Change of address